Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin

Journal of Chemotherapy

Volumn 23, Issue 2, 2011, Pages 80-86

  Shinabarger, D L ^a   Zurenko, G E ^a   Hesje, C K ^b   Sanfilippo, C M ^b   Morris, T W ^b   Haas, W ^b  

^a Micromyx LLC   (United States)

^b BAUSCH AND LOMB   (United States)

Author keywords

Besifloxacin; Efflux pump; Efflux pump inhibitor; Fluoroquinolone

Indexed keywords

BESIFLOXACIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; ETHIDIUM BROMIDE; MOXIFLOXACIN; NORFLOXACIN; RESERPINE; SPARFLOXACIN; TETRACYCLINE; VANADATE SODIUM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 80052727008     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2011.23.2.80     Document Type: Article

References (19)

1. Rouveix B. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria. J Antimicrob Chemother 2007;59:1208-1209.
2. Yoshida H, Bogaki M, Nakamura S, Ubukata K, Konno M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 1990;172:6942-6949.
3. Kaatz GW, McAleese F, Seo SM. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 2005; 49: 1857-1864.
4. Baranova NN, Neyfakh AA. Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae Antimicrob Agents Chemother 1997;41:1396-1398.
5. Garvey MI, Piddock LJ. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob Agents Chemother 2008; 52: 1677-1685.
6. Okusu H, Ma D, Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 1996;178:306-308.
7. Sanchez L, Pan W, Vinas M, Nikaido H. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol 1997;179:6855-6857.
8. Fralick JA. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 1996; 178: 5803-5805.
9. Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 1994;38:1732-1741.
10. Ahmed M, Borsch CM, Neyfakh AA, Schuldiner S. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the an- tihypertensive alkaloid reserpine. J Biol Chem 1993;268:11086-11089.
11. Kinoshita N, Unemoto T, Kobayashi H. Proton motive force is not obligatory for growth of Escherichia coli. J Bacteriol 1984;160:1074-1077.
12. Cho H, Oh Y, Park S, Li Y. Concentration of CCCP should be opti- mi7prl tn Hptprt the pfflnx si/stpm in ni linolnnp-si isrpntihlp Fsrherirhin rnli. J Microbiol 2001;39:62-66.
13. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs 2009;69:1555-1623.
14. Clinical and Laboratory Standards Institute. Methods for Dilution An- timicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, Eighth Edition. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA 2009.
15. Louie A, Brown DL, Liu W, Kulawy RW, Deziel MR, Drusano GL. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother 2007;51:3988-4000.
16. Kaatz GW, Moudgal W, Seo SM. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 2002;50:833-838.
17. Gill MI, Brenwald NP, Wise R. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999;43:187-189.
18. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 2004;10:12-26.
19. Morita Y, Kimura N, Mima T, Mizushima T, Tsuchiya T. Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAOl. J Gen Appl Microbiol 2001; 47: 27-32.